DataLase and Colorcon Inc. Sign Licensing Agreement to Develop DataLase PHARMAMARK
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
NORCROSS, Ga.—DataLase, originator of the DataLase process, has entered into a license agreement with Colorcon Inc. in a move which will see the two companies working together to develop DataLase® PHARMAMARK™, an on-tablet marking technique for the pharmaceutical and nutritional industries.
Colorcon Inc, is a world leading provider of pharmaceutical technologies and a manufacturer of specialty chemicals for related industries. Its core business is the design and technical support of advanced coating systems for pharmaceutical and nutritional supplement dosage forms, and its technological capabilities include assistance in the development of solid dosage formulations.
0 Comments
View Comments
- Companies:
- Colorcon Inc., No-Tox Products Div.
Related Content
Comments